Lohne (oldenburg)

Germany

4 total trials

Filter these 4 trials by phase, condition, sponsor and more.

Open in Search →

A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1) Ended recruitment

2024-513208-32-00 5 2024-12-16 Chronic Spontaneous Urticaria
Efficacy and safety of oral minoxidil in women with hormone-imbalanced hair loss Ended recruitment

2023-503383-17-01 5 2024-10-10 Female androgenetic alopecia
Randomized, Double-Blind, Placebo and Active Comparator Controlled Phase 3 Study of Efficacy and Safety of ESK-001 for Moderate to Severe Pl … Ended

2023-507193-40-00 5 2025-01-16 Moderate to Severe Plaque Psoriasis
Adjusted brodalumab dose compared with standard brodalumab dose in subjects with moderate-to-severe plaque psoriasis and ≥120 kg body weight … Ended

2023-509668-11-00 6 2022-06-15 Moderate-to-severe plaque psoriasis and a body weight ≥120 kg.

Showing 1–4 of 4 trials